Identification of Deregulated Signaling Pathways in Jurkat Cells in Response to a Novel Acylspermidine Analogue-N 4 -Erucoyl Spermidine
Epigenetics Insights · 2018
DOI: 10.1177/2516865718814543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epigenetics Insights, 2018. Verfasst von Syed Shoeb Razvi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Natural polyamines such as putrescine, spermidine, and spermine are crucial in the cell proliferation and maintenance in all the eukaryotes. However, the requirement of polyamines in tumor cells is stepped up to maintain tumorigenicity. Many synthetic polyamine analogues have been designed recently to target the polyamine metabolism in tumors to induce apoptosis. N 4 -Erucoyl spermidine (designed as N 4 -Eru), a novel acylspermidine derivative, has been shown to exert selective inhibitory effects on both hematological and solid tumors, but its mechanisms of action are unknown. In this study, RNA sequencing was performed to investigate the anticancer mechanisms of N 4 -Eru-treated T-cell acute lymphoblastic leukemia (ALL) cell line (Jurkat cells), and gene expression was examined through different tools. We could show that many key oncogenes including NDRG1, CACNA1G, TGFBR2, NOTCH1,2,3, UHRF1, DNMT1,3, HDAC1,3, KDM3A, KDM4B, KDM4C, FOS, and SATB1 were downregulated, whereas several tumor suppressor genes such as CDKN2AIPNL, KISS1, DDIT3, TP53I13, PPARG, FOXP1 were upregulated. Data obtained through RNA-Seq further showed that N 4 -Eru inhibited the NOTCH/Wnt/JAK-STAT axis. This study also indicated that N 4 -Eru-induced apoptosis could involve several key signaling pathways in cancer. Altogether, our results suggest that N 4 -Eru is a promising drug to treat ALL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Cancer Metabolism and Epigenetic Unit, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Cancer and Mutagenesis Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Basic Medical Sciences, College of Medicine and Health Sciences, Hadhramout University, Mukalla, Yemen.
- Bioactive Natural Products Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
Zitieren
APA
Razvi, S. S., Choudhry, H., Hasan, M. N., Hassan, M. A., Moselhy, S. S., Abualnaja, K. O., Zamzami, M. A., Kumosani, T. A., Al-Malki, A. L., Halwani, M. A., Ibrahim, A., Hamiche, A., Bronner, C., Asami, T., & Alhosin, M. (2018). Identification of Deregulated Signaling Pathways in Jurkat Cells in Response to a Novel Acylspermidine Analogue-N 4 -Erucoyl Spermidine. Epigenetics Insights. https://doi.org/10.1177/2516865718814543
Vancouver
Razvi SS, Choudhry H, Hasan MN, Hassan MA, Moselhy SS, Abualnaja KO, et al. Identification of Deregulated Signaling Pathways in Jurkat Cells in Response to a Novel Acylspermidine Analogue-N 4 -Erucoyl Spermidine. Epigenetics Insights. 2018. doi:10.1177/2516865718814543
BibTeX
@article{Razvi2018,
author = {Razvi, Syed Shoeb and Choudhry, Hani and Hasan, Mohammed Nihal and Hassan, Mohammed A and Moselhy, Said Salama and Abualnaja, Khalid Omer and Zamzami, Mazin A and Kumosani, Taha Abduallah and Al-Malki, Abdulrahman Labeed and Halwani, Majed A and Ibrahim, Abdulkhaleg and Hamiche, Ali and Bronner, Christian and Asami, Tadao and Alhosin, Mahmoud},
title = {Identification of Deregulated Signaling Pathways in Jurkat Cells in Response to a Novel Acylspermidine Analogue-N 4 -Erucoyl Spermidine},
journal = {Epigenetics Insights},
year = {2018},
doi = {10.1177/2516865718814543}
}
EUVIMED